TSLA:NASDAQTesla, Inc. Analysis
Data as of 2026-05-28 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Tesla’s technical picture shows a bullish MACD histogram (0.59) and an RSI of 63, suggesting upward momentum while the price sits just below the calculated resistance of $453.40 and well above the support of $368.17, indicating limited upside in the near term. The stock’s volatility is exceptionally high at 41.66% over 30 days and a beta of 2.06, which together with a max drawdown of –29.93% and a fear‑greed index of 92.34 (Extreme Greed) flag considerable risk, especially as trading volume is on a decreasing trend. Fundamental metrics reinforce an overvalued picture: a trailing P/E of 400.33, forward P/E of 175.46, and a price‑to‑book of 20.11 place the market price ($440.36) far above the DCF fair value ($43.06), while the PE‑ratio and the lack of dividend (0% yield) underscore that earnings are not supporting the current valuation. Material news items – the speculative Tesla‑SpaceX merger talk, a 46.5% YoY European sales jump, the robotaxi/Optimus narrative, the upcoming Q1 results release, and a large‑scale vehicle recall – all amplify growth expectations but also add regulatory and execution uncertainty. Consequently, while the stock’s growth narrative remains compelling, the confluence of high volatility, elevated beta, extreme market greed, and a stark valuation gap suggests caution for short‑term traders and a nuanced hold‑or‑buy stance for longer horizons.
Market Outlook
Short Term
< 1 yearKey Factors
- MACD bullish histogram
- price near resistance $453.40
- decreasing volume trend
Medium Term
1–3 yearsKey Factors
- Tesla‑SpaceX merger speculation
- 46.5% YoY Europe sales rise
- robotaxi narrative driving demand
Long Term
> 3 yearsKey Factors
- Extreme Greed fear index 92.34
- high beta 2.06 indicating market sensitivity
- potential DCF fair value gap
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.